Emdeon Third Quarter 2009 Earnings Release Scheduled for November 10, 2009

Wednesday, October 28, 2009 General News J E 4

NASHVILLE, Tenn., Oct. 27 Emdeon (NYSE: EM), a leading provider of healthcare revenue and payment cycle management solutions, today announced that it expects to report financial results for the third quarter of 2009 after the close of market trading on Tuesday, November 10, 2009. The Company also will conduct a conference call/webcast for investors and institutional analysts on Tuesday, November 10, 2009 at 5:00 pm Eastern Time/4:00 pm Central Time to discuss the Company's financial results.

To access Emdeon's live conference call and webcast, dial 800-561-2601 (617-614-3518 for international calls) using conference code 12408553 or visit the investor section of the Company's website: For those unable to listen to the live broadcast, a conference call replay will be available for one week following the conference call by calling 888-286-8010 (617-801-6888 for international calls) using conference code 32630077. A webcast replay will also be archived on the Company's website for at least 30 days following the conference call.

About Emdeon

Emdeon (NYSE: EM) is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon's product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon's comprehensive suite of products and services, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. For more information, visit

Contacts: Investor Relations Tommy Lewis 615.932.3235



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Regado Biosciences to Present at the BIO-Europe Co...
Microbix And Hunan Biopharmaceutical To Build Asia...